Pascale Berthillon

1.0k total citations
29 papers, 748 citations indexed

About

Pascale Berthillon is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Pascale Berthillon has authored 29 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hepatology, 23 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Pascale Berthillon's work include Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (11 papers). Pascale Berthillon is often cited by papers focused on Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (11 papers). Pascale Berthillon collaborates with scholars based in France, United States and Germany. Pascale Berthillon's co-authors include C. Trépo, Fabien Zoulim, Pierre Pradat, Isabelle Bordes, Françoise Berby, Michèle Chevallier, Christian Trépo, Marie-Anne Petit, David Durantel and Arnaud Lemmers and has published in prestigious journals such as Hepatology, Journal of Hepatology and Virology.

In The Last Decade

Pascale Berthillon

28 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascale Berthillon France 15 556 554 134 64 51 29 748
Claire L. Brimacombe United Kingdom 7 352 0.6× 386 0.7× 144 1.1× 65 1.0× 67 1.3× 7 663
David Delgrange France 6 267 0.5× 363 0.7× 106 0.8× 100 1.6× 26 0.5× 7 454
Y‐F Liaw Taiwan 12 583 1.0× 648 1.2× 65 0.5× 33 0.5× 62 1.2× 20 840
Kathrin Hueging Germany 10 318 0.6× 398 0.7× 80 0.6× 68 1.1× 51 1.0× 10 511
H. Kumada Japan 14 879 1.6× 999 1.8× 68 0.5× 49 0.8× 80 1.6× 29 1.1k
S Iino Japan 14 571 1.0× 494 0.9× 121 0.9× 18 0.3× 83 1.6× 49 836
Akihiro Nasu Japan 17 462 0.8× 558 1.0× 78 0.6× 26 0.4× 68 1.3× 44 758
Efsevia Albanis United States 11 882 1.6× 919 1.7× 96 0.7× 17 0.3× 132 2.6× 11 1.1k
Maria Stella De Mitri Italy 11 497 0.9× 506 0.9× 93 0.7× 14 0.2× 39 0.8× 23 642

Countries citing papers authored by Pascale Berthillon

Since Specialization
Citations

This map shows the geographic impact of Pascale Berthillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascale Berthillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascale Berthillon more than expected).

Fields of papers citing papers by Pascale Berthillon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascale Berthillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascale Berthillon. The network helps show where Pascale Berthillon may publish in the future.

Co-authorship network of co-authors of Pascale Berthillon

This figure shows the co-authorship network connecting the top 25 collaborators of Pascale Berthillon. A scholar is included among the top collaborators of Pascale Berthillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascale Berthillon. Pascale Berthillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Virlogeux, Victor, Pascale Berthillon, Isabelle Bordes, et al.. (2018). Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy. Clinics and Research in Hepatology and Gastroenterology. 42(4). 313–318.
2.
Lebossé, Fanny, Barbara Testoni, Judith Fresquet, et al.. (2016). Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B. Journal of Hepatology. 66(5). 897–909. 122 indexed citations
3.
Petit, Marie-Anne, Pascale Berthillon, Pierre Pradat, et al.. (2015). Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis cases. Clinics and Research in Hepatology and Gastroenterology. 39(6). 699–704. 1 indexed citations
4.
Berthillon, Pascale, et al.. (2011). Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes. Hepatology. 54(2). 406–417. 23 indexed citations
5.
Trépo, Eric, Pierre Pradat, Andrej Potthoff, et al.. (2011). Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology. 54(1). 60–69. 136 indexed citations
6.
Berthillon, Pascale, Pierre Pradat, Isabelle Bordes, et al.. (2010). Association of Anti-E1E2 Antibodies with Spontaneous Recovery or Sustained Viral Response to Therapy in Patients Infected with Hepatitis C Virus. Hepatology. 52(5). 1531–1542. 17 indexed citations
7.
Trépo, Eric, Andrej Potthoff, Pierre Pradat, et al.. (2010). Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease. Journal of Hepatology. 55(1). 38–44. 43 indexed citations
8.
Lucifora, Julie, Isabelle Vincent, Pascale Berthillon, et al.. (2010). Hepatitis B Virus Replication in Primary Macaque Hepatocytes: Crossing the Species Barrier Toward A New Small Primate Model. Hepatology. 51(6). 1954–1960. 20 indexed citations
10.
Petit, Marie-Anne, et al.. (2005). Enveloped particles in the serum of chronic hepatitis C patients. Virology. 336(2). 144–153. 30 indexed citations
11.
Pradat, Pierre, Marianne Maynard, Marı́a Buti, et al.. (2004). The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment. Journal of Medical Virology. 73(3). 392–396. 16 indexed citations
12.
Maynard, M. Travis, Pierre Pradat, Pascale Berthillon, et al.. (2003). Clinical relevance of total HCV Core antigen testing for hepatitis C monitoring and for predicting patients’ response to therapy. Journal of Viral Hepatitis. 10(4). 318–323. 38 indexed citations
13.
Zoulim, Fabien, Pascale Berthillon, B. Seignères, et al.. (2002). Animal models for the study of HBV infection and the evaluation of new anti‐HBV strategies. Journal of Gastroenterology and Hepatology. 17(s4). S460–3. 14 indexed citations
14.
Favre, Daniel, Pascale Berthillon, & C. Trépo. (2001). Removal of cell-bound lipoproteins: a crucial step for the efficient infection of liver cells with hepatitis C virus in vitro. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 324(12). 1141–1148. 13 indexed citations
15.
Andrade, Zilton A., et al.. (2001). Schistosomiasis mansoni and viral B hepatitis in woodchucks. Journal of Hepatology. 34(1). 134–139. 6 indexed citations
17.
Berthillon, Pascale, et al.. (1996). Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5). Journal of Hepatology. 25(1). 15–19. 13 indexed citations
18.
Vitvitski, L., et al.. (1995). Characterization of the third most common genotype of hepatitis C virus in France.. PubMed. 22(1 Suppl). 74–82. 1 indexed citations
19.
Trépo, C., François Habersetzer, François Bailly, et al.. (1994). Interferon therapy for hepatitis C. Antiviral Research. 24(2-3). 155–163. 15 indexed citations
20.
Petit, Marie-Anne, Fabien Zoulim, Pascale Berthillon, et al.. (1994). PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis B. Journal of Hepatology. 20(1). 47–56. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026